On Monday, Elevation Oncology Inc (NASDAQ: ELEV) opened lower -8.48% from the last session, before settling in for the closing price of $0.66. Price fluctuations for ELEV have ranged from $0.50 to $5.83 over the past 52 weeks.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Company’s average yearly earnings per share was noted 36.83% at the time writing. With a float of $52.02 million, this company’s outstanding shares have now reached $59.12 million.
The firm has a total of 29 workers. Let’s measure their productivity. In terms of profitability, gross margin is 50.0%, operating margin of -72425.86%, and the pretax margin is -72250.0%.
Elevation Oncology Inc (ELEV) Breakdown of a Key Holders of the stock
A key investor’s attitude towards the stock of the Biotechnology industry is another important factor to consider. The insider ownership of Elevation Oncology Inc is 12.00%, while institutional ownership is 66.23%.
Elevation Oncology Inc (ELEV) Recent Fiscal highlights
Wall Street market experts anticipate that the next fiscal year will bring earnings of -0.2 per share during the current fiscal year.
According to the Wall Street analysts, stocks earnings will be around 36.83% per share during the next fiscal year. For the long-term projections, market analysts anticipate that the company’s EPS will surge by 11.51% during the next five years compared to -52.56% drop over the previous five years of trading.
Elevation Oncology Inc (NASDAQ: ELEV) Trading Performance Indicators
Check out the current performance indicators for Elevation Oncology Inc (ELEV). In the past quarter, the stock posted a quick ratio of 17.77.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -0.81, a number that is poised to hit -0.22 in the next quarter and is forecasted to reach -0.88 in one year’s time.
Technical Analysis of Elevation Oncology Inc (ELEV)
Analysing the last 5-days average volume posted by the [Elevation Oncology Inc, ELEV], we can find that recorded value of 2.01 million was lower than the volume posted last year of 5.3 million. As of the previous 9 days, the stock’s Stochastic %D was 5.06%. Additionally, its Average True Range was 0.09.
During the past 100 days, Elevation Oncology Inc’s (ELEV) raw stochastic average was set at 22.04%, which indicates a significant increase from 1.53% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 152.53% in the past 14 days, which was higher than the 92.22% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $0.6413, while its 200-day Moving Average is $1.7326. Now, the first resistance to watch is $0.6439. This is followed by the second major resistance level at $0.6819. The third major resistance level sits at $0.7039. If the price goes on to break the first support level at $0.5839, it is likely to go to the next support level at $0.5619. Now, if the price goes above the second support level, the third support stands at $0.5239.
Elevation Oncology Inc (NASDAQ: ELEV) Key Stats
There are currently 59,119K shares outstanding in the company with a market cap of 35.81 million. Presently, the company’s annual sales total 0 K according to its annual income of -45,700 K. Last quarter, the company’s sales amounted to 0 K and its income totaled -12,880 K.
